Infectious diseases Corneal neovascularisation Corneal neovascularisation Corneal transplantation is performed when a patient’s own cornea is damaged, inflamed or deformed, often resulting in loss of visual acuity and/or pain. During the procedure, all or part of the patient’s cornea is replaced with the cornea from a donor. Corneal transplantation normally has a high success rate. This is attributable to the privileged immune status of the cornea, which reduces rejection episodes common in other organ transplant situations. However, when pathological blood vessels invade the cornea, a condition known as pathologic corneal neovascularisation (CNV), this compromises the privileged immune status so the risk of graft rejection becomes much higher. In such situations, such as transplantation due to infection or trauma, reducing corneal neovascularisation in connection with corneal transplant could reduce the risk of graft rejection. This could in turn save both eye sight and free up grafts for additional patients, which is important due to the global shortage of corneal grafts. Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica

For Medical Information in your country, please use the address listed below medicalinfo-eu@immedica.com Austria Bulgaria Croatia Estonia Finland France Germany Hungary Italy Latvia Lithuania Poland Portugal Romania Slovenia Spain Austria with local phone number +43 720 145 001 Czech Republic with local phone number +42 029 633 08 54 France with local phone number +33 178 90 03 64 Germany with local phone number +49 322 299 901 72 Slovakia with local phone number +42 123 332 29 96 Spain with local phone number +34 937 37 01 64 medicalinfo-benelux@immedica.com Belgium The Netherlands Luxembourg medicalinfo-gr@immedica.com Cyprus Greece Malta medicalinfo@immedica.com International including Denmark Iceland Ireland Norway Sweden UK Russia International phone calls +46 (0)8 533 39 500 Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica

Oncology / Haematology Ovarian Cancer Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica